| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |